CD44 and acute lymphoblastic leukemia: They documented decreased CD44 levels after therapy in patients with ALL (range: 1343 ± 5399 vs. 545 ± 63 ng/mL) and AML (range: 1629 ± 953 vs. 394 ± 95 ng/mL, p < 0.01).